Cargando…
Osteopontin in Cardiovascular Diseases
Unprecedented advances in secondary prevention have greatly improved the prognosis of cardiovascular diseases (CVDs); however, CVDs remain a leading cause of death globally. These findings suggest the need to reconsider cardiovascular risk and optimal medical therapy. Numerous studies have shown tha...
Autores principales: | Shirakawa, Kohsuke, Sano, Motoaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301767/ https://www.ncbi.nlm.nih.gov/pubmed/34356671 http://dx.doi.org/10.3390/biom11071047 |
Ejemplares similares
-
T Cell Immunosenescence in Aging, Obesity, and Cardiovascular Disease
por: Shirakawa, Kohsuke, et al.
Publicado: (2021) -
Neutrophils and Neutrophil Extracellular Traps in Cardiovascular Disease: An Overview and Potential Therapeutic Approaches
por: Shirakawa, Kohsuke, et al.
Publicado: (2022) -
Sodium-Glucose Co-Transporter 2 Inhibitors Correct Metabolic Maladaptation of Proximal Tubular Epithelial Cells in High-Glucose Conditions
por: Shirakawa, Kohsuke, et al.
Publicado: (2020) -
Drastic transformation of visceral adipose tissue and peripheral CD4 T cells in obesity
por: Shirakawa, Kohsuke, et al.
Publicado: (2023) -
MerTK Expression and ERK Activation Are Essential for the Functional Maturation of Osteopontin‐Producing Reparative Macrophages After Myocardial Infarction
por: Shirakawa, Kohsuke, et al.
Publicado: (2020)